Controversial Aduhelm Alzheimer Drug's Quick Approval To Be Reviewed: US HHS Now Questions FDA's Decision U.S. HHS will investigate the controversial Aduhelm drug after FDA quickly approved Alzheimer's medicine. by Griffin Davis